Becker Joel's most recent trade in NeuroPace Inc was a trade of 1,126 Common Stock done at an average price of $12.7 . Disclosure was reported to the exchange on May 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroPace Inc | Joel Becker | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.66 per share. | 27 May 2025 | 1,126 | 105,338 | - | 12.7 | 14,255 | Common Stock |
| NeuroPace Inc | Joel Becker | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 99,200 | 99,200 | - | - | Stock Option (Rt to Buy) | |
| NeuroPace Inc | Joel Becker | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 58,500 | 106,464 | - | 0 | Common Stock | |
| NeuroPace Inc | Joel Becker | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.56 per share. | 27 Feb 2025 | 4,506 | 47,964 | - | 12.6 | 56,595 | Common Stock |
| NeuroPace Inc | Joel Becker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 104,720 | 104,720 | - | - | Stock Option (Right to Buy) | |
| NeuroPace Inc | Becker Joel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 52,470 | 52,470 | - | 0 | Common Stock | |
| NeuroPace Inc | Joel Becker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 380,424 | 380,424 | - | - | Stock Option (Rt to Buy) | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 507 | 2,825 (0%) | 0% | - | Common Stock | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2022 | 507 | 0 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.76 per share. | 22 Apr 2022 | 124 | 2,701 (0%) | 0% | 81.8 | 10,138 | Common Stock |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2022 | 2,716 | 2,716 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 828 | 2,564 (0%) | 0% | - | Common Stock | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2022 | 828 | 1,657 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.76 per share. | 21 Jan 2022 | 246 | 2,318 (0%) | 0% | 79.8 | 19,621 | Common Stock |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2021 | 507 | 1,374 (0%) | 0% | - | Common Stock | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Apr 2021 | 507 | 507 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.82 per share. | 22 Apr 2021 | 124 | 1,250 (0%) | 0% | 92.8 | 11,510 | Common Stock |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2021 | 2,485 | 2,485 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2020 | 642 | 1,286 | - | - | Restricted Stock Units | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2020 | 642 | 1,024 (0%) | 0% | - | Common Stock | |
| Integer Holdings Corp | Joel Becker | President, CRM & Neuro | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.19 per share. | 31 Dec 2020 | 157 | 867 (0%) | 0% | 81.2 | 12,747 | Common Stock |